The endless possibilities of Artificial Intelligence (AI) offer new and potentially lucrative frontiers.
Bing Li ‘16 finds himself in this sphere as an innovator. The Christ School alumnus is revolutionizing life science research and winning awards for his Pittsburgh-based company.
MitoAI utilizes an AI-enabled robotic system to automate cell culturing. This increases cell-production and scalability while minimizing the risks of human error and contamination. In doing so, the technology cuts down on time and costs for researchers in academia and the biotech/pharma industry.
Bing co-founded MitoAI with another Carnegie Mellon University student, Xinyu Wang. The two took first place out of 330 entrants in a New York ideas competition and placed third in the University of Pittsburgh's Big Idea Final Competition. They continue to seek investors as they develop the technology.
Bing came to Christ School as an international student from China and went on to receive a B.S. in Kinesiology and Exercise Science from Wake Forest University. From there, he matriculated at Carnegie Mellon, where he earned a double master’s degree in Bioengineering and Biomedical Engineering along with Engineering and Technology Innovation Management.
Bing is currently a PhD candidate in Biomedical Engineering at Carnegie Mellon.